Pfizer submits application for COVID booster dose in children ages 5-11
Yahoo Finance Live reports on Pfizer submitting its application for children to receive a third COVID-19 vaccine dose.
Video Transcript
BRAD SMITH: We've got some breaking news to get to as Pfizer has filed a formal application to the US Food and Drug Administration for an EUA, Emergency Use Authorization, for a booster dose for children of the community vaccine, children 5 through 11 years of age. You're tracking shares there on your screen of PFE. Right now, fractionally lower. We'll keep close tabs on shares of Pfizer here.